COVID-19 vaccination challenge: what have we learned from the Brazilian process?
Lancet Glob Health
.
2022 May;10(5):e613-e614.
doi: 10.1016/S2214-109X(22)00049-3.
Epub 2022 Mar 10.
Authors
Gabriela Lotta
1
,
Michelle Fernandez
2
,
Ellen Kuhlmann
3
,
Clare Wenham
4
Affiliations
1
Department of Public Administration, Getulio Vargas Foundation, São Paulo, Brazil.
2
Institute of Political Science, University of Brasília, Brasília 70910-900, Brazil. Electronic address:
[email protected]
.
3
Clinic for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.
4
Department of Health Policy, London School of Economics, London, UK.
PMID:
35279236
PMCID:
PMC8912931
DOI:
10.1016/S2214-109X(22)00049-3
No abstract available
MeSH terms
Brazil / epidemiology
COVID-19 Vaccines*
COVID-19* / epidemiology
COVID-19* / prevention & control
Humans
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines